Veterinary Drug terms — page 8 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

Deserpidine 17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid, (3b,16b,17a,18b,20a)-methyl ester; Deserpidine; A-11025
Desflurane 2-(Difluoromethoxy)-1,1,1,2-tetrafluoroethane; DESFLURANE; Suprane; 57041-67-5; 2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane; Desfluranum [INN-Latin]; Desflurano [INN-Spanish]; difluoromethyl 1,2,2,2-tetrafluoroethyl ether; I-653; I 653; 1,2,2,2-Tetrafluoroethyl difluoromethyl ether; (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether; C3H2F6O; CHEBI:4445; 1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane; DPYMFVXJLLWWEU-UHFFFAOYSA-N; Desfluranum; Desflurano; Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-, (+-)-; Ethane,2-(difluoromethoxy)-1,1,1,2-tetrafluoro-; UNII-CRS35BZ94Q; Desflurane [USAN:INN]; Suprane (TN); Desflurane (JAN/USP/INN); CRS35BZ94Q; Desfluran-O; HSDB 8058; Desflurane [USAN:USP:INN:BAN]; CHF2OCHFCF3; SCHEMBL62917; Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-; GTPL7156; CHEMBL1200733; CTK5A6200; DTXSID80866606; ZX-AP005907; 5829AE; FCH917950; SBB088129; AKOS006228397; DB01189; VZ31862; CC-26789; LS-65505; SC-62385; DB-053001; TR-019952; FT-0624525; C07519; D00546; 1-(difluoromethoxy)-1,2,2,2-tetrafluoroethane; C-04968; Q419383; (+/-)-2-difluoromethyl 1,2,2,2-tetrafluoroethyl ether; Desflurane; Desflurano [INN-Spanish]
Desvenlafaxine 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol; Desvenlafaxine; 93413-62-8; O-Desmethylvenlafaxine; 4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol; 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol; O-desmethyl venlafaxine; Desvenlafaxine [INN:BAN]; DVS 233; O-Desvenlafaxine; d,l-O-Desmethylvenlafaxine; CHEBI:83527; Wy-45233; KYYIDSXMWOZKMP-UHFFFAOYSA-N; Desvenlafaxine, 97%; 1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol; AK-72949; Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-; Phenol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]-; Khedezla; ODV; Desvenlafaxine (INN); WY 45,233; WY-45,233; HSDB 7993; Khedezla (TN); O-DESMETHYLVENLAFAXINE (ODV); O-desmethyl-venlafaxine; ACMC-20ek0k; EC 700-516-2; CHEMBL1118; SCHEMBL34864; MLS006010042; (S)-Desmethyl Venlafaxine D6; GTPL7158; 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol; BDBM86748; CTK8E8385; KS-00000FZO; DTXSID40869118; HMS3652K16; BCP28517; HY-B0602; PDSP1_001804; PDSP2_001787; s4113; AKOS015896311; CS-2818; DB06700; DS-1282; SB17444; NSC_6918664; NCGC00345883-04; AT-19352; BR-72949; SC-82264; SMR004701214; O-Desmethylvenlafaxine, analytical standard; AB0031560; AX8123273; LS-178212; ST2410953; TR-029259; 4CH-007182; CAS_386750-22-7; FT-0654519; SW219514-2; X4688; O-Desmethylvenlafaxine 0.1 mg/ml in Methanol; D07793; J10126; S-2830; AB01563022_01; 413D628; A844583; Q2419445; 4-[2-Dimethyamino-1-(1-hydroxycyclohexyl)ethyl]phenol; 1-[2-dimethylamino-1-(4-hydroxyphenyl)ethyl]cyclohexanol; 4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol; 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol #; (RS)-1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol; O-Desmethylvenlafaxine solution, 1.0 mg/mL in methanol, certified reference material; O-Desmethylvenlafaxine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material; O-Desmethylvenlafaxine; 4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
Dexamethasone
Dexfenfluramine (alphaS)-N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine; Dexfenfluramine; Adifax
Dexibuprofen (alphaS)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid; Dexibuprofen [USAN:INN:BAN]; Dexibuprofen
Dexpropranolol (2R)-1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol; Dexpropranolol; Despropranolo [DCIT]
Dextromethorphan (9-alpha, 13-alpha, 14-alpha)-3-Methoxy-17-methyl morphinan; Dextromethorphan; 4-21-00-01367 (Beilstein Handbook Reference)
Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine; D-Thyroxine; Dextrothyroxine; 51-49-0; Choloxin; (R)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid; Dextrothyroxinum; UNII-4W9K63FION; DEXTROTHYROXINE SODIUM; D-T4; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine; EINECS 200-102-7; CHEMBL559; 4W9K63FION; D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-; CHEBI:30659; (2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; D-4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzylalanine; C15H11I4NO4; (2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d; Dextrothyroxine [BAN]; D-T4 Thyroid Hormone; CAS-51-48-9; AK-89309; D-Thyroxine, 99%; SCHEMBL61194; GTPL6951; BCBcMAP01_000232; CTK8B9805; KS-00000KLZ; DTXSID60199000; XUIIKFGFIJCVMT-GFCCVEGCSA-N; ACT03142; ZINC3830994; ANW-63155; BDBM50225220; AKOS007930308; API0002505; DB00509; SMP1_000296; NCGC00016228-01; DS-18593; ST075205; AX8033885; LS-175203; TR-018335; FT-0675208; ST24035310; 051T490; C-47152; Q5268499; UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-GFCCVEGCSA-N; Dextrothyroxine; Dextrothyroxinum
Dhpta N,N'-(2-Hydroxy-1,3-propanediyl)bis[N-(carboxymethyl)glycine; 3148-72-9; DHPTA; DPTA; Diaminopropanol tetraacetic acid; 1,3-Diaminopropanol tetraacetic acid; Diaminohydroxypropane tetraacetic acid; 1,3-Diamino-2-propanol-N,N,N',N'-tetraacetic acid; 1,3-Diamino-2-hydroxypropane-N,N,N',N'-tetraacetic acid; Diaminohydroxypropanetetraacetic acid; UNII-949B9ZMO7M; 2-Hydroxy-1,3-propylenediaminetetraacetic acid; Diaminopropanol tetra acetic acid; DPTA-OH; Acetic acid, diaminopropanoltetra-; 2-Hydroxytrimethylenediaminetetra(acetic acid); EINECS 221-575-6; NSC 59816; Diaminopropanol tetraacetic acid (VAN); BRN 1716800; 949B9ZMO7M; 2-(Hydroxytrimethylene)diamine-N,N,N',N',-tetraacetic acid; DTA; ((2-Hydroxytrimethylene)diimino)tetraacetic acid; ((2-Hydroxytrimethylene)dinitrilo)tetraacetic acid; NSC59816; 2,2',2'',2'''-((2-Hydroxypropane-1,3-diyl)bis(azanetriyl))tetraacetic acid; Acetic acid, (diaminopropanol)tetra-; Acetic acid, [(2-hydroxytrimethylene)dinitrilo]tetra-; ACETIC ACID, ((2-HYDROXY-1,3-TRIMETHYLENE)DINITRILO)TETRA-; Glycine, N,N'-(2-hydroxy-1,3-propanediyl)bis(N-(carboxymethyl)-; Glycine, N,N'-(2-hydroxy-1,3-propanediyl)bis[N-(carboxymethyl)-; [(2-Hydroxytrimethylene)diimino]tetraacetic acid; W-109870; Acetic acid, ((2-hydroxytrimethylene)dinitrilo)tetra-; Acetic acid, [(2-hydroxy-1,3-trimethylene)dinitrilo]tetra-; C11H18N2O9; 4-04-00-02459 (Beilstein Handbook Reference); SCHEMBL370921; DTXSID5044653; CTK5C0318; 1,3-DIAMINO-2-PROPANOL-N,N,N',N'-TETRAACETICACID; KS-000013KE; ZINC3861209; ANW-43758; MFCD00004288; NSC-59816; AKOS025310788; WLN: QV1N1VQ1YQ1&N1VQ1V1Q; DB12362; 2-[[3-[bis(carboxymethyl)amino]-2-hydroxy-propyl]-(carboxymethyl)amino]acetic acid; 2-[[3-[bis(carboxymethyl)amino]-2-hydroxypropyl]-(carboxymethyl)amino]acetic acid; 2-OHtrimethylenediaminetetra(acetic acid); 63968-63-8; ACM3148729|1; AS-73160; LS-12258; U749; Acetic acid,3-trimethylene)dinitrilo]tetra-; DB-048051; TR-013386; D1330; FT-0634700; C-19717; Q27271662; 2-(Hydroxytrimethylene)diamine-N,N',N',-tetraacetic acid; 1,3-DIAMINO-2-PROPANOL-N,N,N',N'-TETRAACETIC ACID; Acetic acid, ((2-hydroxytrimethylene)dinitrilo)tetra- (8CI); Glycine,N'-(2-hydroxy-1,3-propanediyl)bis[N-(carboxymethyl)-; N,N'-(2-Hydroxy-1,3-propanediyl)bis[N-(carboxymethyl)glycine; 1,3-Diamino-2-hydroxypropane-N,N,N',N'-tetraacetic acid, 99%; 2,2',2'',2'''-(2-hydroxypropane-1,3-diyl)bis(azanetriyl)tetraacetic acid; 2,2',2'',2'''-[(2-Hydroxypropane-1,3-diyl)dinitrilo]tetraacetic acid; 2-({3-[bis(carboxymethyl)amino]-2-hydroxypropyl}(carboxymethyl)amino)acetic acid; 2-[[3-(BIS(CARBOXYMETHYL)AMINO)-2-HYDROXY-PROPYL]-(CARBOXYMETHYL)AMINO ]ACETIC ACID; Diaminohydroxypropanetetraacetic acid; 4-04-00-02459 (Beilstein Handbook Reference)
Diatrizoic acid 3,5-bis(acetylamino)-2,4,6-triiodobenzoic acid; Diatrizoate; G 2-75
Dibromothymoquinone 2,5-Dibromo-3-methyl-6-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione; DIBROMOTHYMOQUINONE; 29096-93-3; Dbmib; 2,5-Dibromo-3-isopropyl-6-methylbenzoquinone; 2,5-Dibromo-6-isopropyl-3-methyl-1,4-benzoquinone; 2,5-Dibromo-3-methyl-6-isopropyl-p-benzoquinone; 2,5-Dibromo-3-isopropyl-6-methylbenzo-1,4-quinone; CHEBI:19371; 2,5-dibromo-3-methyl-6-(1-methylethyl)cyclohexa-2,5-diene-1,4-dione; 2,5-dibromo-3-isopropyl-6-methyl-1,4-benzoquinone; 2,5-dibromo-3-methyl-6-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione; 2,5-Cyclohexadiene-1,4-dione, 2,5-dibromo-3-methyl-6-(1-methylethyl)-; 2,5-Dibromo-3-methyl-6-isopropyl-1,4-benzoquinone; 2,5-dibromo-3-methyl-6-(propan-2-yl)cyclohexa-2,5-diene-1,4-dione; Dibromothymolquinone; EINECS 249-431-8; DBIMB; ACMC-20aobe; 2,5-Dibromothymoquinone; 3,6-Dibromothymoquinone; 2,5-dibromo-3-methyl-6-propan-2-ylcyclohexa-2,5-diene-1,4-dione; SCHEMBL919786; CHEMBL1231418; CTK4G2711; DTXSID60183343; GHHZELQYJPWSMG-UHFFFAOYSA-N; ZINC2011646; MFCD00009967; AKOS015889026; DB04646; FCH1319954; VZ22699; CC-07685; DB-047524; TC-171185; FT-0638830; 2,5-dibromo-3-methyl-6-isopropylbenzoquinone; p-Mentha-3,6-diene-2,5-dione, 3,6-dibromo-; 096D933; A819764; C-19709; SR-01000883712; 2,5-Dibrome-6-isopropyl-3-methyl-1,4-benzoquinone; J-017389; SR-01000883712-1; Q17539331; 2,5-Dibromo-3-isopropyl-6-methylcyclohexa-2,5-diene-1,4-dione; 2,5-bis(bromanyl)-3-methyl-6-propan-2-yl-cyclohexa-2,5-diene-1,4-dione; 2,5-Cyclohexadiene-1,4-dione,2,5-dibromo-3-methyl-6-(1-methylethyl)-; Dibromothymoquinone; EINECS 249-431-8
Dichloralphenazone 1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one compd. with 2,2,2-trichloro-1,1-ethanediol (1:2); Dichloralantipyrine; Dichloralantipyrin
Dichloroacetic acid 2,2-Dichloroacetic acid; Dichloroacetic acid; 4-02-00-00498 (Beilstein Handbook Reference)
Dichlorvos Phosphoric acid 2,2-dichloroethenyl dimethyl ester; Dichlorvos; 4-01-00-02063 (Beilstein Handbook Reference)
Diclofenac 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid; Diclofenac; BRN 2146636
Diclofenac sodium 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid, Sodium salt (1:1); Diclofenac sodium [USAN:USP:JAN]; Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monosodium salt
Dienestrol 4,4'-(1,2-Diethylidene-1,2-ethanediyl)bisphenol; dienestrol; Dehydrostilbestrol; Dienoestrol; 84-17-3; Cycladiene; (E,E)-Dienestrol; Dienol; Estraguard; Restrol; Dehydrostilboestrol; Oestrodienol; Dienesterol; Estragard; Hormofemin; Oestrovis; Willnestrol; alpha-Dienestrol; para-Dien; Dienestrol (E,E); Dienoestrol bp; Estrodienol; Follidiene; Oestrodiene; Oestrasid; p,p'-(Diethylideneethylene)diphenol; E,E-Dienestrol; 13029-44-2; Di(p-oxyphenyl)-2,4-hexadiene; Dinestrol; Estroral; Follormon; Gynefollin; Oestroral; Sexadien; Teserene; Agaldog; Dinovex; Retalon; 3,4-Bis(4-hydroxyphenyl)-2,4-hexadiene; UNII-RRW32X4U1F; MLS000069528; 3,4-Bis(p-hydroxyphenyl)-2,4-hexadiene; 4,4'-Hydroxy-gamma,delta-diphenyl-beta,delta-hexadiene; NSC 59809; Dienestrolo [DCIT]; 4,4'-(Diethylideneethylene)diphenol; 4,4'-(1,2-Diethylidene-1,2-ethanediyl)bisphenol; RRW32X4U1F; Phenol, 4,4'-(diethylideneethylene)di-; SMR000058597; 2,4-Hexadiene, 3,4-bis(4-hydroxyphenyl)-; Dienestrolum [INN-Latin]; NFDFQCUYFHCNBW-SCGPFSFSSA-N; Dienestrolo; Dienestrolum; Phenol, 4,4'-(1,2-diethylidene-1,2-ethanediyl)bis-; Di(para-oxyphenyl)-2,4-hexadiene; Phenol, 4,4'-(1,2-diethylidene-1,2-ethanediyl)bis-, (E,E)-; DSSTox_CID_2382; DSSTox_RID_76566; DSSTox_GSID_22382; para,para'-(Diethylideneethylene)diphenol; CCRIS 9121; 3,4-Bis(para-hydroxyphenyl)-2,4-hexadiene; HSDB 3313; Phenol, 4,4'-(diethylideneethylene)di-, trans-, (E,E)-; Phenol, 4,4'-((1E,2E)-1,2-diethylidene-1,2-ethanediyl)bis-; EINECS 201-519-7; Dienoestrol [Nonsteroidal oestrogens]; Dienestrol, (E,E)-Isomer; 4,4'-Dihydroxy-gamma,delta-diphenyl-beta,delta-hexadiene; Dienestrol [INN]; 4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol; 4,4'-hexa-2,4-diene-3,4-diyldiphenol; Dienestrol (USP/INN); SR-01000003032; DV; CHEBI:4518; Dienestrol [USP:INN:BAN]; DV (TN); CAS-84-17-3; Prestwick_52; NCGC00016335-01; (E,E)-4,4'-(Diethylideneethylene)diphenol; Opera_ID_421; 4-[4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol; alpha-dienestrol diacetate; Prestwick2_000798; Prestwick3_000798; Spectrum5_000875; CHEMBL1018; SCHEMBL52170; BSPBio_000936; BSPBio_002177; MLS001077274; MLS002207222; MLS002222156; SPECTRUM1500241; 4,4'-(2E,4E)-hexa-2,4-diene-3,4-diyldiphenol; BPBio1_001030; cid_667476; GTPL7160; SCHEMBL2896853; ZINC1283; BDBM40491; HMS502G13; DTXSID20873495; HMS1570O18; HMS1920G04; HMS2091M14; HMS2097O18; HMS2232M11; HMS3714O18; Pharmakon1600-01500241; HY-B1403; Tox21_110378; 2375AH; CCG-40189; NSC756734; s1858; AKOS015902490; Tox21_110378_1; CS-4911; DB00890; NSC-756734; IDI1_000771; NCGC00018153-03; NCGC00018153-04; NCGC00018153-05; NCGC00018153-06; NCGC00018153-07; NCGC00018153-10; NCGC00022210-03; NCGC00022210-04; NCGC00178779-01; NCGC00178779-02; AC-13162; SBI-0051344.P003; AB2000337; LS-104381; TR-026060; D0449; C08090; D00898; Dienestrol, VETRANAL(TM), analytical standard; AB00051967_16; J-005782; Q5274949; SR-01000003032-2; SR-01000003032-4; 4,4'-((2E,4E)-hexa-2,4-diene-3,4-diyl)diphenol; 4,4'-[(2E,4E)-2,4-Hexadiene-3,4-diyl]diphenol; BRD-K55106630-001-01-0; BRD-K95309561-001-05-6; BRD-K95309561-001-15-5; Dienestrol, European Pharmacopoeia (EP) Reference Standard; Dienestrol, United States Pharmacopeia (USP) Reference Standard; 4,4'-Dihydroxy-.gamma.,.delta.-diphenyl-.beta.,.delta.-hexadiene; Phenol, 4,4'-(1,2-diethylidene-1,2-ethanediyl)bis-, (E,E)- (9CI); Dienestrol; Agaldog
Diethyl phosphonate Phosphonic acid, Diethyl ester; Diethyl hydrogen phosphite; 4-01-00-01329 (Beilstein Handbook Reference)
Diethyldithiocarbamic acid Diethylcarbamodithioic acid; Ditiocarb; 4-04-00-00389 (Beilstein Handbook Reference)
Diethylene glycol diethyl ether 1,1'-oxybis[2-ethoxy]ethane; Diethyl carbitol; 4-01-00-02394 (Beilstein Handbook Reference)
Diethylpropion 2-(Diethylamino)-1-phenyl-1-propanone; DIETHYLPROPION; Amfepramone; Diethylpropione; Amfepramon; Anorex; Tepanil; Nopropiophenone; Adiposon; Amphepramon; Amphepramone; Frekentine; Danylen; Dobesin; Magrene; Neobes; Tylinal; alpha-Benzoyltriethylamine; 90-84-6; Amfepramonum; Cegramine; Obesitex; Prefamone; Regenon; Silutin; Derfon; alpha-Diethylaminopropiophenone; Anfepramona; Diethylcathinone; Amfepramonum [INN-Latin]; Anfepramona [INN-Spanish]; 2-(Diethylamino)propiophenone; Amfepramone [INN]; 1-Propanone, 2-(diethylamino)-1-phenyl-; 1-Phenyl-2-diethylamino-1-propanone; 2-(Diethylamino)-1-phenyl-1-propanone; DEA No. 1610; 2-(diethylamino)-1-phenylpropan-1-one; Propiophenone, 2-(diethylamino)-; UNII-I535TOV6LY; UNII-P1A5AE6Q2R; Amfepramone (INN); UR 1423; Fenyl-(1-diethylaminoethyl)keton [Czech]; Amphepramonum hydrochloride; HSDB 3059; Diethylpropione hydrochloride; EINECS 202-019-1; BRN 2804400; I535TOV6LY; P1A5AE6Q2R; CHEBI:4530; Propiophenone, 2-diethylamino-; DIETHYLPROPION, DONYLEN,DOBESIN; Anfamon; Keramik; Keramin; Modulor; Parabolin; Phepranon; C06954; D07444; 2-Diethylaminopropiophenone; Tenuate hydrochloride; C13H19NO; (+)-Amfepramone; (-)-Amfepramone; (+-)-diethylpropion; Diethylpropion (BAN); Amfepramone, (+)-; Amfepramone, (-)-; Fenyl-(1-diethylaminoethyl)keton; Diethylpropion, (+}-; Diethylpropion, (-)-; NCGC00167475-01; (+)-2-Diethylaminopropiophenone; (-)-2-Diethylaminopropiophenone; (+/-)-diethylpropion; SCHEMBL27330; 1-Propanone, 2-(diethylamino)-1-phenyl-, (+)-; 1-Propanone, 2-(diethylamino)-1-phenyl-, (-)-; 4-14-00-00144 (Beilstein Handbook Reference); GTPL7161; CHEMBL1194666; DTXSID6022929; XXEPPPIWZFICOJ-UHFFFAOYSA-N; MFCD00056154; AKOS025401369; DB00937; J4.327C; MCULE-3905795013; 2-Diethylaminopropiophenone hydrochloride; 39648-49-2; 39648-50-5; AC-13099; SC-99119; 2-(Diethylamino)-1-phenyl-1-propanone #; LS-125137; 1-Phenyl-2-diethylamino-1-propanone hydrochloride; Q2356505; BRD-A37288617-003-01-4; Diethylpropion; 4-14-00-00144 (Beilstein Handbook Reference)
Diglyme 1,1'-Oxybis[2-methoxyethane]; Diglyme; 111-96-6; 2-Methoxyethyl ether; Bis(2-methoxyethyl) ether; 1-Methoxy-2-(2-methoxyethoxy)ethane; DIETHYLENE GLYCOL DIMETHYL ETHER; Di(2-Methoxyethyl) ether; Poly-Solv; 2,5,8-Trioxanonane; Dimethyl carbitol; (2-Methoxyethyl) ether; Ethane, 1,1'-oxybis[2-methoxy-; Ether, bis(2-methoxyethyl); Methyldiglyme; Glyme 2; Bis(2-methoxyethyl)ether; Diglycol methyl ether; Dimethoxydiglycol; Dimethyldiglycol; Diethyl glycol dimethyl ether; 2-(2-Methoxyethoxy)-1-methoxyethane; 1,1'-Oxybis(2-methoxyethane); UNII-M4BH3X0MVZ; 2-methoxyethylether; NSC 59726; Glyme-2; HSDB 72; diethylene glycol dimethylether; diethyleneglycol dimethyl ether; CCRIS 6212; Ethanol, 2,2'-oxybis-, dimethyl ether; 2,2'-oxybis(1-methoxyethane); Ethane, 1,1'-oxybis(2-methoxy-; 2,2'-oxybis[1-(methyloxy)ethane]; EINECS 203-924-4; M4BH3X0MVZ; BRN 1736101; AI3-28583; DTXSID1024621; CHEBI:46784; SBZXBUIDTXKZTM-UHFFFAOYSA-N; CH3-O-CH2-CH2-O-CH2-CH2-O-CH3; DSSTox_CID_4621; DSSTox_RID_77470; DSSTox_GSID_24621; 1,1'-oxybis[2-methoxyethane]; CAS-111-96-6; M2M; Bis(2-methoxyethyl) ether, 99%, extra pure; Bis(2-methoxyethyl) ether, 99+%, Extra Dry, AcroSeal(R); Dimethyldigol; dimethyl digol; Dimethylcarbitol; methoxyethyl ether; Bis(2-methoxyethyl) ether, 99+%, Extra Dry over Molecular Sieve, AcroSeal(R); 2,8-Trioxanonane; MFCD00008503; 2-methoxylethyl ether; 2-methyoxyethyl ether; (2-methoxyethyl)ether; bis(2methoxyethyl)ether; Dimethoxydiethylene glycol; di-(2-methoxyethyl)ether; ACMC-1C6FP; SCHEMBL398; diethyleneglycoldimethylether; EC 203-924-4; bis-(2-methoxy ethyl)ether; bis-(2-methoxyethyl) ether; bis-(2-methoxy ethyl) ether; KSC175G5H; Ethane,1'-oxybis[2-methoxy-; diethylene-glycol dimethyl ether; CH3OCH2CH2OCH2CH2OCH3; 1,1'-Oxybis(2-methoxy)ethane; CHEMBL1234162; CTK0H5353; KS-00000VEJ; 2,2'-Oxybisethanol dimethyl ether; NSC59726; ZINC1689760; Ethanol,2'-oxybis-, dimethyl ether; Tox21_202340; Tox21_300077; ANW-16354; LS-544; NSC-59726; STL280534; 1-(2-methoxyethoxy)-2-methoxyethane; 1-methoxy-2-(2-methoxyethoxyl)ethane; AKOS000120199; DB02935; Diethylene glycol dimethyl ether(DEDM); MCULE-8598811835; RTR-032438; TRA0068788; 1-Methoxy-2-(2-methoxyethoxy)ethane #; NCGC00247897-01; NCGC00247897-02; NCGC00253963-01; NCGC00259889-01; SC-76648; DB-060140; TR-032438; B0498; CS-0017205; FT-0624894; ST24038063; 15135-EP2272491A1; 15135-EP2272813A2; 15135-EP2272832A1; 15135-EP2275395A2; 15135-EP2284169A1; 15135-EP2287153A1; 15135-EP2287154A1; 15135-EP2287161A1; 15135-EP2287162A1; 15135-EP2289897A1; 15135-EP2292592A1; 15135-EP2292607A2; 15135-EP2295415A1; 15135-EP2298747A1; 15135-EP2298770A1; 15135-EP2298828A1; 15135-EP2301924A1; 15135-EP2301933A1; 15135-EP2308812A2; 15135-EP2308862A1; 15135-EP2311827A1; 15135-EP2311829A1; 15135-EP2314584A1; 15135-EP2316832A1; 15135-EP2316833A1; 15135-EP2371797A1; 15135-EP2371798A1; 15135-EP2371800A1; 15135-EP2371804A1; 49760-EP2287153A1; 49760-EP2311825A1; Q865952; Diethylene glycol dimethyl ether, analytical standard; Diethylene glycol dimethyl ether, anhydrous, 99.5%; J-509864; Q-200977; Bis(2-methoxyethyl)ether 100 microg/mL in Cyclohexane; Diethylene glycol dimethyl ether, ReagentPlus(R), 99%; F1908-0129; Z1258578237; Diethylene glycol dimethyl ether, Vetec(TM) reagent grade, 98%; Diethylene glycol dimethyl ether, puriss. p.a., >=99.5% (GC); Diethylene glycol dimethyl ether, spectrophotometric grade, >=99%; InChI=1/C6H14O3/c1-7-3-5-9-6-4-8-2/h3-6H2,1-2H; Diethylene glycol dimethyl ether, puriss., absolute, over molecular sieve (H2O <=0.005%), >=99.5% (GC); Diethylene glycol dimethyl ether; 4-01-00-02393 (Beilstein Handbook Reference)
Digoxin (3 beta, 5 beta, 12 beta)-3[O-2,6-Dideoxy-beta-D-ribo-hexapyranosyl-(14)-O-2,6-dideoxy-beta-D-ribo-hexapyranosyl-(14)-2,6-dideoxy-beta-D-ribo-hexapyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide; Digoxin; 5-18-04-00381 (Beilstein Handbook Reference)
Dihydralazine 1,4-Dihydrazinylphthalazine; DIHYDRALAZINE; 484-23-1; Ophthazin; Dihydralazin; Dihydrallazin; Dihydrallazine; Hypopresol; Nepresol; Nepresolin; Nepressol; Tonolysin; 1,4-Dihydrazinophthalazine; Dihydrazinophthalazine; Cassella 532; 1,4-Dihydrazinonaphthalazine; 1,4-dihydrazinylphthalazine; Dihydralazine [INN:BAN]; Dihydralazinum [INN-Latin]; UNII-PCU411F5L6; Dihidralazina [INN-Spanish]; C 7441; (4-hydrazinylphthalazin-1-yl)hydrazine; NSC 526654; CCRIS 7576; Phthalazine, 1,4-dihydrazino-; EINECS 207-605-0; 1,4-Phthalazinedione, 2,3-dihydro-, dihydrazone; BRN 0183442; PCU411F5L6; 2,3-Dihydro-1,4-phthalazinedione dihydrazone; VQKLRVZQQYVIJW-UHFFFAOYSA-N; NSC-526654; NCGC00159421-02; NCGC00159421-03; (1Z)-4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine; DSSTox_CID_2935; DSSTox_RID_76795; DSSTox_GSID_22935; phthalazinyl-1,4-dihydrazine; DihidralaziDihydralazinum; CAS-484-23-1; Dihydrazinophthalazin; 1,4-Dihydrazino-phthalazine; Dihydralazine (INN); Phthalazine,4-dihydrazino-; 5-25-17-00465 (Beilstein Handbook Reference); CHEMBL35505; SCHEMBL149629; 1,4-bis(hydrazino)phthalazine; DTXSID0022935; SCHEMBL14318435; 1, 2,3-dihydro-, dihydrazone; CTK7F1878; CHEBI:134841; (4-diazanylphthalazin-1-yl)diazane; KS-000025JH; ZINC4474539; Tox21_111653; BDBM50088433; FCH843175; NSC526654; SBB057529; AKOS006276458; AKOS025393367; AKOS030240650; Tox21_111653_1; (4-hydrazinyl-1-phthalazinyl)hydrazine; DB12945; GS-0013; MCULE-7385790272; OR310825; DB-002370; LS-109152; FT-0602022; ST51005791; 84D231; D07170; A827533; AE-641/40262237; Q408370; SR-01000944956; SR-01000944956-1; 1,4-Phthalazinedione, 2,3-dihydro-, dihydrazone (9CI); Dihydralazine; C 7441
Dihydrostreptomycin O-2-Deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1fwdarw2)-O-5-deoxy-3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl-(1fwdarw4)-N1,N3-bis(aminoiminomethyl)-D-streptamine; Dihydrostreptomycin; Abiocine
Diisopropyl methylphosphonate Diisopropylmethyl phosphonate; Diisopropyl methylphosphonate; 4-04-00-03501 (Beilstein Handbook Reference)
Diltiazem (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; Diltiazem; BRN 3573079
Dimercaprol 2,3-Dimercapto-1-propanol; DIMERCAPROL; 2,3-Dimercapto-1-propanol; 59-52-9; 2,3-Dimercaptopropanol; Dithioglycerine; Sulfactin; Dicaptol; dimercaptopropanol; 2,3-Dithiopropanol; British Anti-Lewisite; 1,2-Dithioglycerol; British antilewisite; 1-Propanol, 2,3-dimercapto-; Antoxol; Dimersol; Panobal; BAL in Oil; 1,2-Dimercapto-3-propanol; Dimercaprol propanol; Dimercaprolum; Dithioglycerol; 2,3-Dimercaptol-1-propanol; Usaf me-1; 3-Hydroxy-1,2-propanedithiol; BAL; alpha,beta-Dithioglycerol; Dimerkaprol; 2,3-Mercaptopropanol; 2,3-Dimercaptopropan-1-ol; Glycerol, 1,2-dithio-; Sulfactin (VAN); Dimerkaprol [Czech]; Dimercaprolo [DCIT]; Dithioglycerol (VAN); 2,3-bis(sulfanyl)propan-1-ol; Dimercaptopropanol (VAN); DMP (VAN); 2,3-Mercaptopropan-1-ol; Dimercaprolum [INN-Latin]; NSC 4646; 2,3-disulfanylpropan-1-ol; NSC 39515; C3H8OS2; CCRIS 3616; CHEBI:64198; HSDB 4004; EINECS 200-433-7; BRN 1732058; Dimercaptol; 1-Propanol, 2,3-dimercapto; .alpha.,.beta.-Dithioglycerol; AI3-61820; NSC4646; WQABCVAJNWAXTE-UHFFFAOYSA-N; Glycerol,2-dithio-; MFCD00004864; WLN: SH1YSH1Q; 1-Propanol,3-dimercapto-; W-105317; Dimercaprolo; 2,3-Dimercapro; NSC16865; 2,3-Dimercapto-1-propanol, 97.0-100.5%; Dimercaprol [INN:BAN:JAN]; Anti-Lewisite; Dimercaprol [USP:INN:BAN:JAN]; Spectrum_001965; ACMC-1AQYA; 2, 3-dimercaptopropanol; Spectrum2_001218; Spectrum4_001275; Spectrum5_001622; BAL (TN); CHEMBL1597; DSSTox_CID_20461; DSSTox_RID_79496; DSSTox_GSID_40461; SCHEMBL15969; KBioGR_001890; KBioSS_002524; 2,3 -dimercapto-1-propanol; 2,3-dimercapto-propan-1-ol; 4-01-00-02770 (Beilstein Handbook Reference); DivK1c_000997; SPBio_001036; 2,3-Disulfanyl-1-propanol #; Dimercaprol (JP17/USP/INN); DTXSID5040461; CTK3J1382; HMS503G15; KBio1_000997; KBio2_002516; KBio2_005084; KBio2_007652; NINDS_000997; Pharmakon1600-01500252; BCP18145; HY-B1285; NSC-4646; NSC39515; Tox21_110014; ANW-33288; BDBM50103608; CCG-39156; NSC-39515; NSC760094; AKOS015895110; DB06782; FCH1115700; NSC-760094; RTR-037211; TRA0055820; CAS-59-52-9; IDI1_000997; NCGC00013216-01; CC-26872; NCI60_001345; SBI-0051351.P002; DB-053404; LS-122148; TR-037211; CS-0013059; D0621; FT-0625021; C02924; D00167; AB00051971_02; 004D864; 2,3-Dimercapto-1-propanol, >=98% (iodometric); C-00943; Q413968; SR-05000001839; SR-05000001839-1; InChI=1/C3H8OS2/c4-1-3(6)2-5/h3-6H,1-2H; Dimercaprol; 4-01-00-02770 (Beilstein Handbook Reference)
Dimethyl fumarate (2E)-2-Butenedioic acid 1,4-dimethyl ester; Dimethyl fumarate; 4-02-00-02205 (Beilstein Handbook Reference)
Dinoprost (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid; Dinoprost; U-14583
Dinoprostone 5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxo-rosta-5,13-dien-1-oic acid; Dinoprostone; U-12062
Diphenhydramine 2-(Diphenylmethoxy)-N,N-dimethylethanamine; diphenhydramine; 58-73-1; Benadryl; Benzhydramine; Alledryl; Probedryl; Antistominum; Dihidral; 2-(Benzhydryloxy)-N,N-dimethylethanamine; Benzhydraminum; Benzhydroamina; Diphantine; Difenhydramin; Allergical; Bagodryl; Baramine; Benachlor; Benadrin; Benodine; Benzantine; Benzhydril; Betramin; Debendrin; Dermistina; Dermodrin; Desentol; Diabenyl; Diabylen; Dibondrin; Difedryl; Drylistan; Histaxin; Hyadrine; Ibiodral; Medidryl; Mephadryl; Novamina; Syntedril; Amidryl; Antomin; Benapon; Benodin; Benylan; Benylin; Dabylen; Dylamon; Nausen; Diphenylhydramine; Difenidramina; Automin; Dimedrol base; Difenhidramina; Allergina; Benzhydryl; Diphenhydraminum; Antitussive; 2-(Benzhydryloxy)-N,N-dimethylethylamine; Dibenil; Hydramine; O-Benzhydryldimethylaminoethanol; Silphen; Beldin; Diphen; Belix; Dimehydrinate; Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-; Difenidramina [Italian]; FAR 90X2; Dibendrin; Difenhidramina [INN-Spanish]; Diphenhydraminum [INN-Latin]; alpha-(2-Dimethylaminoethoxy)diphenylmethane; PM 255; beta-Dimethylaminoethanol diphenylmethyl ether; Diphenhydramine [INN:BAN:JAN]; N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine; 2-(diphenylmethoxy)-N,N-dimethylethanamine; 2-(Diphenylmethoxy)-N,N-dimethylethylamine; beta-Dimethylaminoethylbenzhydrylether; UNII-8GTS82S83M; N-(Benzhydryloksy-etylo)dwumetyloamina; [2-(diphenylmethoxy)ethyl]dimethylamine; CCRIS 1959; 2-Diphenylmethoxy-N,N-dimethylethylamine; HSDB 3066; EINECS 200-396-7; Ethylamine, N,N-dimethyl-2-(diphenylmethoxy)-; N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]; CHEMBL657; 2-diphenylmethoxy-N,N-demthylethanamine; beta-dimethylaminoethyl benzhydryl ether; beta-Dimethylamino-aethyl-benzhydryl-aether [German]; BRN 1914136; N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE; 8GTS82S83M; CHEBI:4636; Allerdryl; Ethylamine, 2-(diphenylmethoxy)-N,N-dimethyl-; ZZVUWRFHKOJYTH-UHFFFAOYSA-N; Allergan; S51; NCGC00015335-07; Benhydramin; AK113999; Allergeval; Dimedryl; Dryistan; Rigidil; Syntodril; Aleryl; Diphenylhydramin; Ben-allergin; Allergan B; DSSTox_CID_2949; DSSTox_RID_76803; DSSTox_GSID_22949; Q-201002; CAS-58-73-1; Restamin (TN); N-[2-(Diphenylmethoxy)ethyl]-N,N-dimethylamine; Benadryl (hydrochloride); NCGC00015335-09; CAS-147-24-0; Difenhydramine; Dobacen; beta-Dimethylamino-aethyl-benzhydryl-aether; Allergan (Salt/Mix); Eldadryl (Salt/Mix); Histacyl (Salt/Mix); Restamin (Salt/Mix); Spectrum_000980; 2-benzhydryloxyethyl-N,N-dimethylammonium; Antitussive (Salt/Mix); Prestwick0_000065; Prestwick1_000065; Prestwick2_000065; Prestwick3_000065; Spectrum2_000961; Spectrum3_000400; Spectrum4_000520; Spectrum5_000915; Lopac-D-3630; 2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine; EC 200-396-7; Cambridge id 6699980; SCHEMBL4064; Lopac0_000377; Oprea1_254625; BSPBio_000249; BSPBio_002219; Dimethylamine benzhydryl ester; KBioGR_001099; KBioSS_001460; 2PM; MLS002222276; BIDD:GT0152; Diphenhydramine (JP17/INN); DivK1c_000368; SPBio_000961; SPBio_002170; BPBio1_000275; GTPL1224; 2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride; DTXSID4022949; KBio1_000368; KBio2_001460; KBio2_004028; KBio2_006596; KBio3_001439; ZINC20244; N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride; NINDS_000368; O-Benzhydryl(dimethylamino)ethanol; HMS2089E06; HMS2230L19; HMS3373E03; KS-00000G2T; Tox21_110127; BDBM50017674; MFCD31699960; NSC665800; SBB068439; STK103720; AKOS003658554; Tox21_110127_1; (2-Benzhydryloxy-ethyl)-dimethyl-amine; CCG-204472; DB01075; GS-3196; MCULE-6260910826; NSC-665800; SDCCGSBI-0050365.P005; IDI1_000368; NCGC00015335-01; NCGC00015335-02; NCGC00015335-03; NCGC00015335-04; NCGC00015335-05; NCGC00015335-06; NCGC00015335-08; NCGC00015335-10; NCGC00015335-11; NCGC00015335-12; NCGC00015335-13; NCGC00015335-14; NCGC00015335-17; NCGC00024414-03; NCGC00024414-04; NCGC00024414-06; AC-13704; LS-68208; NCI60_002916; NCI60_022782; S 51; SC-35671; SMR001307259; ST024741; SY246339; 2-(Benzohydryloxy)-N,N-dimethylethylamine; N,N-Dimethyl-2-diphenylmethyloxyethylamine; SBI-0050365.P004; 2-(Benzhydryloxy)-N,N-dimethylethanamine #; .beta.-(Dimethylamino)ethyl benzhydryl ether; .beta.-Dimethylamino-aethyl-benzhydryl-aether; 2-(diphenylmethyl)oxy-N,N-dimethylethanamine; AB00053460; D4744; Ethylamine, 2-diphenylmethoxy-N,N-dimethyl-; FT-0625221; ST24039534; 2-(diphenylmethyl)oxy-N,N-dimethyl-ethanamine; 2-[di(phenyl)methoxy]-N,N-dimethylethanamine; .alpha.-(2-Dimethylaminoethoxy)diphenylmethane; C06960; D00300; AB00053460-22; AB00053460-23; AB00053460_24; AB00053460_25; .beta.-(Dimethylamino)ethanol diphenylmethyl ether; 274D173; A831996; Diphenylmethanol, (N,N-dimenthylaminoethyl) ether; L000227; Q413486; BRD-K47278471-003-05-7; BRD-K47278471-003-15-6; 2-[(Phenyl-4-D)(phenyl)methoxy]-N,N-dimethylethanamine; 2122800-18-2; Diphenhydramine; S51
Diphenidol alpha, alpha-Diphenyl-1-piperidinebutanol; Diphenidol; 5-20-02-00249 (Beilstein Handbook Reference)
Diphenylacetic acid 4-09-00-02492 (Beilstein Handbook Reference)
Dipicolinic acid 2,6-Pyridinedicarboxylic acid; Dipicolinic acid; Dipicolinate
Dipyrone 1-[(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]methanesulfonic acid sodium salt (1:1); Dipyrone; Alginodia
Dithioerythritol Dithioerythritol; 6892-68-8; 1,4-Dithioerythritol; (2R,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL; DTE; Dithioerythreitol; 2,3-Butanediol, 1,4-dimercapto-, (2R,3S)-rel-; erythro-1,4-Dimercapto-2,3-butanediol; UNII-R4SVL81GQI; R4SVL81GQI; 1,4-Dithioerythritol (DTE); (2R,3S)-1,4-disulfanylbutane-2,3-diol; (R*,S*)-1,4-Dimercaptobutane-2,3-diol; (2R*,3S*)-1,4-dimercapto-2,3-butanediol; CHEBI:17456; Dithioerythritol, 99+%; ERYTHRITOL, 1,4-DITHIO-; EINECS 229-998-8; BRN 1719756; DTU; (R*,S*)-1,4-Dimercapto-2,3-butanediol; trans-1,4-Dimercaptobutane-2,3-diol; 2,3-Dihydroxy-1,4-dithiolbutane; 2,3-Butanediol, 1,4-dimercapto-, (theta,S)-; erythro-2,3-Dihydroxy-1,4-butanedithiol; (2R,3S)-1,4-bis(sulfanyl)butane-2,3-diol; SCHEMBL78921; 3-01-00-02359 (Beilstein Handbook Reference); 1,4-Dithioerythritol, 99%; CHEMBL1232391; DTXSID40884341; VHJLVAABSRFDPM-ZXZARUISSA-N; 2,3-Dihydroxy-1,4-butanedithiol; DTT; 1,4-Dithioerythritol, >=99.0%; 3591AH; GE5960; KM1229; MFCD00063750; ZINC12341762; AKOS015902817; CS-3034; DB01692; FCH3465601; FS-4113; HY-15916; 1,4-Dithioerythritol, >=99.0% (RT); 1,4-Dithioerythritol, BioXtra, >=99.0%; D1320; FT-0606884; FT-0606913; ST24050184; (2R*,3S*)-1,4-dimercaptobutane-2,3-diol; (2S,3R)-1,4-bis(sulfanyl)butane-2,3-diol; C00950; 1,4-Dithioerythritol, BioUltra, >=99.0% (RT); A836288; Q412701; 2,3-Butanediol, 1,4-dimercapto-, (R*,S*)- (9CI); 1,4-Dithioerythritol, BioReagent, for molecular biology, >=99.0%; Cleland's Reagent DTE "erythro-1,4-Dimercapto-2,3-butanediol" C4H10O2S2 154.25 82-84 degrees 6892-68-8 229-998-8 MFCD00063750 KF2410000 UN3335 9 Y; 3-01-00-02359 (Beilstein Handbook Reference)
Dobutamine 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol; Dobutamine; Dobutamina [INN-Spanish]
Docosahexaenoic acid (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoic acid; Docosahexaenoic acid; CCRIS 7670
Dodecane-trimethylamine N,N,N-Trimethyl-1-dodecanaminium; n-Dodecyltrimethylammonium; Dodecyltrimethylammonium; DODECANE-TRIMETHYLAMINE; Dotac compound; Laurtrimonium; N,N,N-Trimethyl-1-dodecanaminium; N,N,N-trimethyldodecan-1-aminium; DODECYLTRIMETHYLAMMONIUM ION; UNII-GT3793XV5S; 10182-91-9; dodecyl-trimethyl-azanium; GT3793XV5S; CHEBI:41378; 1-Dodecanaminium, N,N,N-trimethyl-; CHEMBL109873; dodecyl(trimethyl)azanium; Lauryltrimethylaminium; dodecyl(trimethyl)ammonium; SCHEMBL93498; CHEMBL1180004; DTXSID4045008; CTK4A0283; Dodecyl-trimethyl-ammonium; bromide; 1-Dodecanaminium,N,N,N-trimethyl-; ZINC1673414; BDBM50060599; DB02779; MCULE-8554349544; NCGC00164250-02; NCGC00164250-03; Q27093728; Dodecyltrimethylammonium; Dotac compound
Dodecyl hydrogen sulphate Sulfuric acid, Monododecyl ester; Dodecyl sulfate; 3-01-00-02186 (Beilstein Handbook Reference)
Dodecylguanidine DODECYLGUANIDINE; 1-dodecylguanidine; 112-65-2; Guanidine, dodecyl-; laurylguanidine; Guanidine, N-dodecyl-; UNII-RNB1NU2RGG; n-dodecylguanidine; RNB1NU2RGG; CHEBI:74880; HILAYQUKKYWPJW-UHFFFAOYSA-N; 2-dodecylguanidine; 1-laurylguanidine; N-Dodecyl-guanidine; Verichem N 2000; aminododecylcarboxamidine; SCHEMBL21643; CHEMBL74474; DTXSID8041907; CTK0H3333; HILAYQUKKYWPJW-UHFFFAOYSA-; C12-G; ZINC1666747; LS-5961; NCGC00166187-01; ST45026285; 112D652; Q27144990; InChI=1/C13H29N3/c1-2-3-4-5-6-7-8-9-10-11-12-16-13(14)15/h2-12H2,1H3,(H4,14,15,16); Dodine
Domoic acid (2-Carboxy-4-(5-carboxy-1-methyl-1,3-hexadienyl)-3-pyrrolidineacetic acid, Stereoisomer; Domoic acid; BRN 5768789
Domperidone 5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one; domperidone; 57808-66-9; Motilium; Nauzelin; Domperidonum; DomperidoMotinorm; Costi; Domperidonum [INN-Latin]; Domperidona [INN-Spanish]; C22H24ClN5O2; 4-(5-Chloro-2-oxo-1-benzimidazolinyl)-1-[3-(2-oxobenzimidazolinyl)propyl]piperidine; R-33812; NSC299589; KW-5338; R 33,812; Domperidone (Motilium); 5-Chloro-1-(1-(3-(2-oxo-1-benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone; EINECS 260-968-7; R33812; UNII-5587267Z69; KW 5338; BRN 0903774; 6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one; MLS000069343; CHEMBL219916; CHEBI:31515; NSC-299589; 5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one; 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; Domperidon; 5-Chloro-1-[1-[3-(2-oxo-1-benzimidazolinyl)propyl]-4-piperidyl]-2-benzimidazolinone; DSSTox_CID_25116; DSSTox_RID_80682; DSSTox_GSID_45116; 1-(3-(4-(5-chloro-2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[d]imidazol-2(3H)-one; 2H-Benzimidazol-2-one, 5-chloro-1-(1-(3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; 5-Chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one; W-105440; 5587267Z69; Motillium; Motilium (TN); 2H-Benzimidazol-2-one, 1,3-dihydro-5-chloro-1-(1-(3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one; SMR000326802; CAS-57808-66-9; Lopac-D-122; SR-01000003002; Domperidone [USAN:BAN:INN:JAN]; Nauzelin OD; Domperidone,(S); 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; 5-chloro-1-{1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one; Domperidone [USAN:INN:BAN:JAN]; Prestwick_794; Domperidone,Motilium; R-33,812; NCI299589; HS-0067; PubChem15679; Spectrum_000391; Opera_ID_616; SpecPlus_000825; Prestwick0_000461; Prestwick1_000461; Prestwick2_000461; Prestwick3_000461; Spectrum4_000087; D-122; Biomol-NT_000022; NCIStruc1_001686; NCIStruc2_001819; Lopac0_000427; SCHEMBL43729; BSPBio_002350; GTPL965; KBioGR_000354; KBioSS_000871; 5-24-02-00402 (Beilstein Handbook Reference); MLS000859942; MLS001306482; MLS002222324; DivK1c_006921; SPECTRUM2300212; SPBio_002501; BPBio1_000620; BPBio1_001185; DTXSID1045116; CTK8B3352; Domperidone (JP17/USAN/INN); KBio1_001865; KBio2_000871; KBio2_003439; KBio2_006007; KS-00000PNZ; BBC/763; FGXWKSZFVQUSTL-UHFFFAOYSA-N; HMS1922N04; HMS2089C14; HMS2093N22; HMS2096C21; HMS2230N18; HMS3261E16; HMS3269O13; HMS3370L03; HMS3413F15; HMS3656M21; HMS3677F15; HMS3713C21; Pharmakon1600-02300212; BCP28265; Domperidone 1.0 mg/ml in Methanol; EBD46624; HY-B0411; ZINC4175569; ZX-AS004963; Tox21_110056; Tox21_500427; ANW-42358; BBL028136; BDBM50241107; BG0172; CCG-37870; CD0227; GP3849; MFCD00069256; NCGC00014670; NSC759575; s2461; STK622843; AKOS005555858; Tox21_110056_1; AC-2037; CS-2511; DB01184; Domperidone, powder, >=98% (HPLC); LP00427; MCULE-4430288884; NSC 299589; NSC-759575; SDCCGSBI-0050412.P004; NCGC00014670-01; NCGC00014670-02; NCGC00014670-03; NCGC00014670-04; NCGC00014670-05; NCGC00014670-06; NCGC00014670-07; NCGC00014670-08; NCGC00014670-09; NCGC00014670-10; NCGC00014670-11; NCGC00014670-12; NCGC00014670-13; NCGC00014670-14; NCGC00014670-16; NCGC00014670-17; NCGC00015306-01; NCGC00021472-02; NCGC00021472-03; NCGC00021472-04; NCGC00021472-05; NCGC00021472-06; NCGC00021472-07; NCGC00021472-08; NCGC00097773-01; NCGC00261112-01; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one; LS-33301; NCI60_002512; SC-18462; SMR000058969; AB0110085; AB1009278; AB00052423; D4125; EU-0100427; FT-0625588; SW196931-3; D01745; AB00052423-06; AB00052423-07; AB00052423_08; AB00052423_09; 808D669; L000230; Q424238; R 33812; SR-01000003002-2; SR-01000003002-4; SR-01000003002-7; BRD-K38305202-001-02-6; BRD-K38305202-001-08-3; Domperidone, European Pharmacopoeia (EP) Reference Standard; 5-Chloro-1-[1-[3-(2-oxo-1-benzimidazolyl)propyl]-4-piperidyl]benzimidazol-2-one; 2H-Benzimidazol-2-one,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-; 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(1-methyl-1H-indol-5-yl)-2H-1,2,4-triazol-3(4H)-one; 5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo -1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-d ihydro-2H-benzimidazol-2-one; 5-Chloro-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1- yl)propyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one; 5-chloro-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidine-4-yl]-1,3-dihydro-2H-benzimidazol-2-one; 5-chloro-1-{1-[3(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one; 5-chloro-1-{1-[3-(1,3-dihydro-2-oxo-2H-benzimidazol-1-yl)propyl]-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one; 5-Chloro-1-{1-[3-(2-hydroxy-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-2,3-dihydro-1H-benzoimidazol-2-ol; 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-1-yl)propyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one; 5-Chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one(domperidone); DOMPERIDONE5-Chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one; Domperidone; 5-24-02-00402 (Beilstein Handbook Reference)
Dopamine dopamine; 4-(2-Aminoethyl)benzene-1,2-diol; 51-61-6; Hydroxytyramin; Oxytyramine; Dopamin; 3-Hydroxytyramine; 3,4-dihydroxyphenethylamine; intropin; Dophamine; 2-(3,4-dihydroxyphenyl)ethylamine; 4-(2-Aminoethyl)catechol; hydroxytyramine; Dopaminum; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)-1,2-benzenediol; 3,4-Dihydroxyphenylethylamine; Dopamina; L-DOPAMINE; ASL 279; Pyrocatechol, 4-(2-aminoethyl)-; 1,2-Benzenediol, 4-(2-aminoethyl)-; Dopaminum [INN-Latin]; Dopamina [INN-Spanish]; Dopamine [INN:BAN]; 3-Hydroxtyramine; alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; KW-3-060; Sinemet; 4-(2-aminoethyl)-pyrocatechol; UNII-VTD58H1Z2X; NSC 173182; a-(3,4-Dihydroxyphenyl)-b-aminoethane; HSDB 3068; 4-(2-Aminoethyl)-1,2-bezenediol; EINECS 200-110-0; VTD58H1Z2X; CHEBI:18243; VYFYYTLLBUKUHU-UHFFFAOYSA-N; NSC-173182; LDP; NCGC00015519-05; Pyrocatechol, 4-(2-aminoethyl)- (8CI); DSSTox_CID_2420; 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); DSSTox_RID_76584; DSSTox_GSID_22420; .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane; 62-31-7 (HYDROCHLORIDE); CAS-51-61-6; Dopamine (INN); Medopa (TN); NSC169105; Intropin [*hydrochloride*]; 4-(2-Aminoethyl)-1,2-benzenediol hydrochloride; SR-01000075366; .beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; m-Hydroxytyramine-; Dopamine (USAN)(*hydrochloride*); IP 498; Intropin (Salt/Mix); Spectrum_001012; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; CHEMBL59; Spectrum2_001023; Spectrum3_000406; Spectrum4_000525; Spectrum5_000945; Lopac-H-8502; 3- HYDROXYTYRAMINE; Biomol-NT_000001; bmse000909; bmse000933; 3-Hydroxytyramine HCl salt; SCHEMBL8505; 1, 4-(2-aminoethyl)-; Lopac0_000586; Oprea1_088821; BSPBio_001932; GTPL940; KBioGR_001129; KBioGR_002388; KBioGR_002484; KBioSS_001492; KBioSS_002393; KBioSS_002491; cid_65340; BIDD:ER0506; DivK1c_000780; SPECTRUM1505155; SPBio_001205; BPBio1_001123; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; DTXSID6022420; BDBM55121; CTK4E3164; KBio1_000780; KBio2_001492; KBio2_002388; KBio2_002484; KBio2_004060; KBio2_004956; KBio2_005052; KBio2_006628; KBio2_007524; KBio2_007620; KBio3_001152; KBio3_002867; KBio3_002962; ZINC33882; cMAP_000036; cMAP_000065; NINDS_000780; HMS3743I03; Tox21_110167; 2-(3, 4-Dihydroxyphenyl)ethylamine; 2-(3,4-dihydroxyphenyl) ethylamine; ANW-54385; BBL013043; LS-159; NSC173182; SBB004044; STK301601; 3,4-DihydroxyphenylA currencythylamin; AKOS003790978; Tox21_110167_1; CCG-204675; DB00988; FS-5341; MCULE-7558764100; SDCCGSBI-0050568.P005; 2-(3,4-Dihydroxyphenyl)-1-ethanamine; 4-(2-Amino-ethyl)-benzene-1,2-diol; 4-(2-Aminoethyl)-1,2-benzenediol #; IDI1_000780; UPCMLD0ENAT5885989:001; NCGC00015519-01; NCGC00015519-02; NCGC00015519-03; NCGC00015519-04; NCGC00015519-07; NCGC00015519-08; NCGC00015519-09; NCGC00015519-10; NCGC00015519-11; NCGC00096050-01; NCGC00096050-02; NCGC00096050-03; NCGC00096050-04; NCGC00096050-05; AK100905; BP-23276; ST048774; 4-(2-aminoethyl)pyrocatechol; hydrochloride; SBI-0050568.P004; ST2405321; TX-016804; 4CH-018780; FT-0698513; T7923; 2-(4-Hydroxy-5-oxylatophenyl)-1-ethanaminium; C03758; D07870; 13510-EP2269989A1; 13510-EP2270011A1; 13510-EP2272537A2; 13510-EP2272825A2; 13510-EP2272847A1; 13510-EP2275420A1; 13510-EP2277882A1; 13510-EP2280010A2; 13510-EP2281559A1; 13510-EP2281815A1; 13510-EP2281819A1; 13510-EP2284169A1; 13510-EP2284170A1; 13510-EP2284171A1; 13510-EP2286811A1; 13510-EP2287161A1; 13510-EP2287162A1; 13510-EP2287165A2; 13510-EP2287166A2; 13510-EP2292620A2; 13510-EP2295437A1; 13510-EP2295439A1; 13510-EP2298312A1; 13510-EP2298313A1; 13510-EP2298731A1; 13510-EP2298734A2; 13510-EP2298758A1; 13510-EP2298759A1; 13510-EP2298775A1; 13510-EP2298776A1; 13510-EP2301540A1; 13510-EP2301933A1; 13510-EP2305260A1; 13510-EP2305633A1; 13510-EP2305640A2; 13510-EP2305644A1; 13510-EP2305648A1; 13510-EP2305650A1; 13510-EP2305652A2; 13510-EP2305656A1; 13510-EP2305659A1; 13510-EP2305664A1; 13510-EP2305675A1; 13510-EP2305689A1; 13510-EP2308828A2; 13510-EP2308867A2; 13510-EP2308870A2; 13510-EP2308875A1; 13510-EP2311494A1; 13510-EP2311801A1; 13510-EP2311802A1; 13510-EP2311803A1; 13510-EP2311818A1; 13510-EP2311827A1; 13510-EP2311828A1; 13510-EP2311835A1; 13510-EP2314571A2; 13510-EP2316470A2; 13510-EP2316836A1; 13510-EP2371814A1; 4-(2-azanylethyl)benzene-1,2-diol; hydrochloride; AB00053463-12; AB00053463_13; AB00053463_14; L000232; Q170304; SR-01000075366-7; 4-(2-Aminoethyl)-1,2-benzenediol
Dorsomorphin 6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)pyrazolo[1,5-a]pyrimidine; (6-(4-(2-Piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine; Dorsomorphin
Doxorubicin (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; Doxorubicin; ADM
Doxycycline (4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; doxycycline; Doxytetracycline; Vibramycin; 564-25-0; DoxicicliDoxycyclinum; Monodox; Oracea; Doxy-Caps; Vibravenos; Doxycycline (anhydrous); Vibra-tabs; 6-Deoxytetracycline; Azudoxat; Deoxymykoin; Doxitard; Doxivetin; Doxycycline hyclate; Investin; Liviatin; Vibramycine; Doxycen; Ronaxan; Spanor; 6alpha-Deoxy-5-oxytetracycline; Doxy-Puren; alpha-Doxycycline; Doxy-Tabs; alpha-6-Deoxyoxytetracycline; 5-Hydroxy-alpha-6-deoxytetracycline; 6-alpha-Deoxy-5-oxytetracycline; Doxycyclin; 6-Deoxyoxytetracycline; Dossiciclina [DCIT]; Doxiciclina [Italian]; alpha-6-Deoxy-5-hydroxytetracycline; BMY-28689; Doxycyclinum [INN-Latin]; Doxycycline (internal use); Doxiciclina [INN-Spanish]; BU-3839T; DOXYCYCLINE CALCIUM; Doxycycline anhydrous; Oxytetracycline, 6-deoxy-; DOXY; HSDB 3071; EINECS 209-271-1; UNII-334895S862; DossicicliDoxychel; CHEBI:50845; MMV000011; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-; Supracyclin; Doxysol; Jenacyclin; Vibramycin Novum; (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; GS-3065; Doxycycline-Chinoin; 334895S862; Zenavod; DOXCYCLINE ANHYDROUS; Doxycycline (TN); Doxychel (TN); 2-Naphthacenecarboxamide, 4-alpha-S-(dimethylamino)-1,4,4a-alpha-5,5a-alpha,6,11,12a-octahydro-3,5-alpha,10,12,12a-alpha-pentahydroxy-6-alpha-methyl-1,11-dioxo-; Vivox (*Hyclate); Doxycycline (INN); DMSC (*Fosfatex); NSC633557; Monodox (*monohydrate); BMY28689; BU 3839T; 24390-14-5; BMY 28689; Vibramycin (*monohydrate); GS-3065 (*monohydrate); Doxycycline [USAN:INN:BAN]; SR-01000075844; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)-; Anhydrous doxycycline; Doxycycline (200mg/day) or Placebo; Doxycycline (hyclate); AB08 (*Fosfatex); Spectrum_000807; 94088-85-4; Spectrum2_000143; Spectrum3_000408; Spectrum4_000527; Spectrum5_000947; UPCMLD-DP021; CHEMBL1433; Lopac0_000405; SCHEMBL40930; SCHEMBL66828; BSPBio_001936; KBioGR_001133; KBioSS_001287; DivK1c_000345; SPBio_000246; CHEMBL436921; GTPL6464; SCHEMBL1176275; 4-Epioxytetracycline, 6-deoxy-; DTXSID0037653; SCHEMBL17826665; SCHEMBL19270298; UPCMLD-DP021:001; BCBcMAP01_000024; KBio1_000345; KBio2_001287; KBio2_003855; KBio2_006423; KBio3_001156; DTXSID80992212; JBIWCJUYHHGXTC-AKNGSSGZSA-N; NINDS_000345; RPRXAHFLWOCXQL-AKNGSSGZSA-N; SGKRLCUYIXIAHR-AKNGSSGZSA-N; HMS2090E06; HY-N0565; LMPK07000001; s5159; ZINC16052277; AKOS015900372; ZINC100056779; ZINC100302137; ZINC100611210; ZINC109562088; API0002491; CCG-204498; DB00254; MCULE-4368118692; SDCCGSBI-0050391.P005; IDI1_000345; SMP1_000107; NCGC00161602-01; NCGC00161602-03; NCGC00161602-04; NCGC00161602-05; NCGC00188979-01; (4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS); AS-13499; I455; LS-93868; SC-15766; SBI-0050391.P004; LS-187766; CS-0009105; FT-0603476; 1368-EP2269978A2; 1368-EP2269985A2; 1368-EP2269991A2; 1368-EP2284150A2; 1368-EP2284151A2; 1368-EP2284152A2; 1368-EP2284153A2; 1368-EP2284155A2; 1368-EP2284156A2; 1368-EP2284164A2; 1368-EP2287140A2; 1368-EP2287148A2; 1368-EP2287150A2; 1368-EP2289871A1; 1368-EP2295402A2; 1368-EP2295419A2; 1368-EP2298732A1; 1368-EP2301534A1; 1368-EP2301912A2; 1368-EP2301913A1; 1368-EP2301914A1; 1368-EP2301916A2; 1368-EP2305637A2; 1368-EP2305640A2; 1368-EP2308863A1; 1368-EP2311451A1; 1368-EP2311796A1; 1368-EP2311797A1; 1368-EP2311798A1; 1368-EP2311799A1; 1368-EP2316450A1; C06973; D07876; AB00053465-03; AB00053465_04; AB00053465_05; 564D250; Doxycycline, Antibiotic for Culture Media Use Only; Q422442; SR-01000075844-7; W-105517; (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)-; 4-(Dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboximidic acid; 7164-70-7; Doxycycline; Azudoxat
Droperidol 1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2H-benzimidazol-2-one; droperidol; 548-73-2; Droleptan; Dehydrobenzperidol; Inapsine; Dridol; Properidol; Sintodril; Sintosian; Inapsin; Vetkalm; Halkan; Deidrobenzperidolo; DHBP; Inopsin; Innovar; Inappin; Innovan; McN-JR-4749; Inoval; Dehidrobenzperidol; Droperidolum; Droperidolo; Thalamanol; Dihidrobenzperidol; Dehydrobenzoperidol; Droperidolo [DCIT]; R-4749; McN-JR 4749; Droperidolum [INN-Latin]; component of Innovar; R 4749; NSC 169874; UNII-O9U0F09D5X; 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; CCRIS 9070; 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; C22H22FN3O2; HSDB 3320; R4749; 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; EINECS 208-957-8; BRN 0579168; CHEMBL1108; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; MLS000028671; CHEBI:4717; O9U0F09D5X; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-; RMEDXOLNCUSCGS-UHFFFAOYSA-N; NSC169874; NSC-169874; 1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one; 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-; NCGC00016504-01; CAS-548-73-2; SMR000058855; DSSTox_CID_2973; DSSTox_RID_76811; DSSTox_GSID_22973; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one; W-105600; Neurolidol; Ina.psi.ne; Ina.psi.n; Ino.psi.n; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-; 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-; Droleptan (TN); 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one; 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one; 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; Droperidol [USAN:INN:BAN:JAN]; SR-05000001546; INAPSINE (TN); Droperidol USP; 1-(1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2h-benzimidazol-2-one; Prestwick_705; Innovar (Salt/Mix); Droperidol [USAN:USP:INN:BAN:JAN]; HS-0065; Leptanal (Salt/Mix); Leptofen (Salt/Mix); Spectrum_001220; Thalamonal (Salt/Mix); Innovar-vet (Salt/Mix); Opera_ID_1751; Prestwick0_000360; Prestwick1_000360; Prestwick2_000360; Prestwick3_000360; Spectrum2_001386; Spectrum3_001426; Spectrum4_000407; Spectrum5_001305; SCHEMBL41426; BSPBio_000459; BSPBio_003132; KBioGR_000674; KBioSS_001700; 5-24-02-00388 (Beilstein Handbook Reference); MLS000758203; MLS001148120; MLS001424134; MLS002153445; DivK1c_000103; SPECTRUM1501002; SPBio_001372; SPBio_002380; BPBio1_000505; Droperidol (JP17/USP/INN); GTPL7172; DTXSID6022973; CTK7B9727; CTK8F9380; HMS500F05; KBio1_000103; KBio2_001700; KBio2_004268; KBio2_006836; KBio3_002352; KS-00000XNO; NINDS_000103; HMS1569G21; HMS1921B03; HMS2051L06; HMS2092O16; HMS2096G21; HMS2232M09; HMS3374B05; HMS3393L06; HMS3652M12; HMS3713G21; Pharmakon1600-01501002; HY-B1240; Tox21_110461; BDBM50017705; CCG-39004; MFCD00083290; NSC757819; s4096; STL453109; ZINC19796080; AKOS015960779; Tox21_110461_1; AC-3537; CCG-101004; CS-4886; DB00450; NC00254; NSC-757819; VA10777; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; 3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; IDI1_000103; NCGC00016504-02; NCGC00016504-03; NCGC00016504-04; NCGC00016504-05; NCGC00016504-06; NCGC00016504-09; NCGC00016504-17; NCGC00094884-01; NCGC00094884-02; CPD000058855; H920; LS-33253; SAM001247013; SBI-0051628.P002; Droperidol 1.0 mg/ml in Dimethyl Sulfoxide; AK00094085; FT-0655846; SW220019-1; D00308; AB00052191_04; AB00052191_05; WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF; 548D732; A830387; C-55183; L001006; Q174259; SR-05000001546-1; SR-05000001546-2; SR-05000001546-3; BRD-K97158071-001-05-8; BRD-K97158071-001-08-2; Droperidol, British Pharmacopoeia (BP) Reference Standard; Droperidol, European Pharmacopoeia (EP) Reference Standard; Droperidol, United States Pharmacopeia (USP) Reference Standard; 2H-Benzimidazol-2-one,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; 2H-Pyrrolo[3,2-b]pyridin-2-one, 1,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-; gamma-[4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl]-p-fluorobutyrophenone; 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]butan-1-one; 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1h-benzimidazol-1-yl)-3,6-dihydropyridin-1(2h)-yl]butan-1-one; 1-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-3H-benzoimidazol-2-one; 1-{1-[4-(4-Chloro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Droperidol); 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,5,6-tetrahydropyridin-4-yl] -1,3-dihydro-2H-benzimidazol}-2-one; 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; Droperidol; R 4749